Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Cevimeline improves symptoms of xerostomia in animal models, patients with Sjogren's syndrome

Nov. 10, 1998

Knoll's promising new treatment for RA covered in depth at rheumatology congress

Nov. 10, 1998

New series from Agouron with inhibitory activity against MMPs and TNF-alpha production

Nov. 10, 1998

Merck finally reveals chemical structure of lead COX-2 inhibitor

Nov. 6, 1998

Eisai to collaborate with Toyama in development, marketing of DMARD

Nov. 5, 1998

Inhibitors of cell adhesion with antiinflammatory activity developed at Japan Energy

Nov. 5, 1998

SmithKline Beecham describes new cannabinoid receptor agonists

Nov. 5, 1998

Aryl C-glycosides as selectin inhibitors jointly developed by Sankyo, Glycomed

Nov. 5, 1998

Potent and selective COX-2 inhibitors from Merck Frosst useful for inflammation

Nov. 4, 1998

Korean laboratory prepares new series of TNF-alpha inhibitors

Nov. 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.